Telesis Bio Inc Ár/Könyv
Mi az Telesis Bio Inc Ár/Könyv?
A Ár/Könyv az Telesis Bio Inc - 11,809.24
Mi a Ár/Könyv meghatározása?
Az ár-könyv arány aránya a vállalat részvényértéke és az egy részvényre jutó könyv szerinti érték arányát jelenti.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Ár/Könyv a Health Care szektor a NASDAQ-on cégekben a Telesis Bio Inc -hoz képest
Mit csinál Telesis Bio Inc?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
ár/könyv -hoz hasonló cégek Telesis Bio Inc
- Fura Gems nak Ár/Könyv 6,553.13 van
- Core Gold nak Ár/Könyv 6,615.38 van
- CIIG Merger Corp nak Ár/Könyv 6,997.50 van
- XCD nak Ár/Könyv 8,159.84 van
- Toron nak Ár/Könyv 9,516.85 van
- XIB I Capital nak Ár/Könyv 11,572.74 van
- Telesis Bio Inc nak Ár/Könyv 11,809.24 van
- Forum Merger III nak Ár/Könyv 13,272.14 van
- AXIOS Sustainable Growth Acquis nak Ár/Könyv 13,601.31 van
- CF Finance Acquisition II nak Ár/Könyv 23,861.36 van
- dMY Technology nak Ár/Könyv 26,950.17 van
- New Tech Minerals nak Ár/Könyv 29,197.79 van
- PT Aneka Tambang Tbk nak Ár/Könyv 36,136.92 van